Pelican Therapeutics, Inc.

Selective Stimulation of Memory CD8+ T Cells

Selective Stimulation of Memory CD8+ T Cells

Introducing first-in-class therapeutics to achieve in vivo regulatory T cell expansion in humans

Introducing first-in-class therapeutics to achieve in vivo regulatory T cell expansion in humans

Oct 4, 2018

Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator

Oct 30, 2017

Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its $15.2 Million CPRIT Grant Award

Oct 23, 2017

Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards

Home About Us Products Science & Publications News Contact Us Careers

Copyright © 2020 Pelican Therapeutics, Inc., a subsidiary of Heat Biologics. All rights reserved. Privacy Policy Sitemap